Jeffrey S. Buguliskis

Exciting News! Wolfram & Quake together at SynBioBeta 2024. You definitely won't want to miss this. Get your tickets now! https://t.co/7S8mOPyFXU

John Cumbers @johncumbers

Wendy Lawton (@wendylawton1), a wonderful mentor of mine in grad school, said that if you wanted your work to be widely read you needed to make sure it contained peanut butter and chocolate. These are two wonderful things on their own, but bring them together and you get https://t.co/3Nd9E1oxfk

RT @MJD007: Wow could be an interesting opportunity for @Ginkgo / Synbio in space. You @jrkelly were just writing on X about biology in sp…

RT @SynBioBeta: One of our great writers, @TarasavaKatia, is attending @Biofabricate_ right now and is telling us about some great new thin…

A new @SynBioBeta Insight article from @sachinxr about the use of SynBio to combat rare infectious diseases. Check it out! https://t.co/eIm3956D8K

Great article to start the new year! @FoodBeerScience uncovers the fascinating science at @Inner_Plant. https://t.co/4np2kbaxu2

Just a fun (and informative) holiday article for the SynBio caroler in your soul. @Juggling_Doctor nails this one, and I had fun coming up with the imagery :) @SynBioBeta #SynBioCarol https://t.co/sPK8h36U6W

Why go for the milk when you can get the lactoferrin for cheaper! New Insight article from @Juggling_Doctor where he dives into the fascinating world at @TurtleTree and their take on cellular agriculture. @SynBioBeta https://t.co/6TpGBIDKRW

In this week's new Insight article, we glimpse into how our planet's vast biodiversity continues to provide synthetic biologists with an array of tools that allow them to shape the future of biotech and sustainability. @SynBioBeta https://t.co/nJVNSWLOyN

RT @SynBioBeta: #CRISPR-Based Therapy Receives Regulatory Green Light in the UK: https://t.co/8hLSBUnj9i

In this new & comprehensive Insight article, @TarasavaKatia uncovers how the synthetic biology community is pushing the boundaries of #AI beyond its uses in biopharma. It's a great read! @SynBioBeta https://t.co/R2ZpBWrj6l

HOT OFF EMBARGO!! Yeast Strain Thrives With Over 50% Synthetic Genome. @SynBioBeta 's intern extraordinaire, Gabrielle David reports on the latest findings from @caiyizhi laboratory. https://t.co/FGA7XY6UIP https://t.co/OdGgZur28K

Is the DNA Data Storage industry ready for prime-time? Find out in this week's Insight article from one of our newest writers @sachinxr, where he takes a dive into the intersection of molecular biology and digital technology. https://t.co/9pDpD6NJdw

They just heard that you haven't bought a ticket to @SynBioBeta 2024 yet...Understandably horrified expression. Buy your ticket now! https://t.co/S46aa7Bn2W #SynBioBeta2024 #SyntheticBiology

microscopic images. @microscopicture

maggot seen through an electron microscope https://t.co/AtC6EEBOXE

In this week's Insight article, @SynBioBeta's own @FionaRMischel caught up with @stefvangrieken, Co-founder and CEO of @cradlebio, to discuss the relationship the US Pharma industry has with AI. Take a read, it's a great interview! https://t.co/5nt5fDLrDX

RT @johncumbers: Come join the party, and our synthetic biology community! May 6-9th in San Jose! The SynBioBeta Early Bird ends at Midnig…

Check out our latest Insight article by @Juggling_Doctor, a look at how a SynBio collaboration is tackling rare diseases. Insightful and thoughtfully written. @SynBioBeta #ToCureARose https://t.co/sNF36ldxxr

Did you catch our latest Insight article from our newest writer @JTsangWrites? Phages are wildly fascinating and could become hugely important medically. It's a great piece. Check it out! @SynBioBeta https://t.co/D9AbbsiPIy https://t.co/b5WbuPdrvL